Summaries of essential medicines related guidance from a range of professional and government bodies across clinical specialties

Specialty Guidance for Allergy and Immunology

Summaries of essential medicines related guidance for allergy and immunology from a range of professional and government bodies.

Kidney Care UK guidance during COVID-19

Provides information about COVID-19 for patients with kidney disease, including those with transplants.

British Transplantation Society guidance during COVID-19

Summary of the documents holding key information regarding the coronavirus and professional practice from the British Transplant Society.

UK Primary Immunodeficiency Network change in advice for children (under 18 years) during COVID-19

Summary of the change in advice for children with Primary Immunodeficiency in the context of COVID-19.

European Academy of Allergy and Clinical Immunology guidance during COVID-19

Links to allergy-related statements and journal articles in the context of COVID-19.

UK Primary Immunodeficiency Network advice for healthcare professionals looking after patients with immunodeficiency during COVID-19

Summary of advice for healthcare professionals looking after patients with immunodeficiency in the context of COVID-19.

NICE Rapid Evidence summary for anakinra for COVID-19 associated secondary haemophagocytic lymphohistiocytosis

A summary of the evidence on the use of anakinra for treatment of haemophagocytic lymphohistiocytosis secondary to COVID-19 infection.

Allergy UK FAQs during COVID-19

A summary of the Allergy UK Frequently Asked Questions on coronavirus aimed at people living with allergy.

NICE Rapid Guideline for management of children and young people who are immunocompromised during COVID-19

This guideline advises on how to maximise the safety of immunocompromised children and young people during the COVID-19 pandemic.

Other Specialty Guidance

Advice for other specialties is presented below. We’re working through and updating and improving this section to make it easier for users.

Summary of COVID-19 medicines guidance: Respiratory disorders

30 March 2021This page summarises and signposts to medicine related guidance we’re aware of from professional and government bodies relating to coronavirus and respiratory disorders. Our advice…

Summary of COVID-19 medicines guidance: Critical care

12 January 2021This page summarises and signposts to medicine related guidance we’re aware of from professional and government bodies relating to coronavirus and critical care. Our advice…

Summary of COVID-19 medicines guidance: Diabetes

11 May 2021This page summarises and signposts to medicine related guidance we’re aware of from professional and government bodies relating to coronavirus and diabetes. Our advice is…

Summary of COVID-19 medicines guidance: Infection and infectious diseases

29 December 2020This page summarises and signposts to medicine related guidance we’re aware of from professional and government bodies relating to coronavirus and infection and infectious diseases.…

Summary of COVID-19 medicines guidance: Cardiovascular system disorders

21 July 2021This page summarises and signposts to medicine related guidance we’re aware of from professional and government bodies relating to coronavirus and cardiovascular system disorders. Our…

Summary of COVID-19 medicines guidance: Mental health and illness

21 July 2021This page summarises and signposts to medicine related guidance we’re aware of from professional and government bodies relating to coronavirus and mental health and illness.…

Summary of COVID-19 medicines guidance: Stroke

20 July 2021This page summarises and signposts to medicine related guidance we’re aware of from professional and government bodies relating to coronavirus and stroke. Our advice is…

Summary of COVID-19 medicines guidance: Palliative and End of Life Care

2 June 2021This page summarises and signposts to medicine related guidance we’re aware of from professional and government bodies relating to coronavirus and palliative and end of…

Summary of COVID-19 medicines guidance: Haematological disorders

19 May 2021This page summarises and signposts to medicine related guidance we’re aware of from professional and government bodies relating to coronavirus and haematological disorders. Our advice…

Summary of COVID-19 medicines guidance: Obstetrics and gynaecology

19 May 2021This page summarises and signposts to medicine related guidance we’re aware of from professional and government bodies relating to coronavirus and obstetrics and gynaecology. Our…

Summary of COVID-19 medicines guidance: Endocrine system disorders

13 May 2021This page summarises and signposts to medicine related guidance we’re aware of from professional and government bodies relating to coronavirus and endocrine system disorders. Our…

Summary of COVID-19 medicines guidance: Later life

11 May 2021This page summarises and signposts to medicine related guidance we’re aware of from professional and government bodies relating to coronavirus and later life disorders. Our…

Summary of COVID-19 medicines guidance: Learning disabilities

11 May 2021This page summarises and signposts to medicine related guidance we’re aware of from professional and government bodies relating to coronavirus and learning disabilities. Our advice…
Search Other Specialty Guidance